WESTON, Fla., June 5, 2020 /PRNewswire/ - Apotex is expanding the previously announced Retail Level recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg that was initiated on May 29, ...

The US Food and Drug Administration (FDA) has recommended voluntary recall of certain extended-release (ER) versions of metformin because testing has revealed excessive levels of ...

Two pharmaceutical companies recently issued voluntary recalls for extended-release versions of the diabetes drug metformin, because it may contain high levels of a cancer-causing chemical, according ...

Issue: Products contain or may contain a nitrosamine impurity, N-nitrosodimethylamine (NDMA), above or close to the acceptable limit. What to do: You should not stop taking your metformin drug without ...

Apotex has recalled all its Metformin Hydrochloride Extended-Release Tablets 500 mg in the United States for too much of carcinogen NDMA, the same “impurity” that got all the Zantac yanked earlier ...

Please provide your email address to receive an email when new articles are posted on . Nostrum Laboratories, Inc., is voluntarily recalling two lots of metformin hydrochloride extended-release ...

Pharma Major Lupin Limited (Lupin) announced today that its US subsidiary, Lupin Pharmaceuticals Inc., has launched its Metformin HCl ER Tablets, 500 mg and 1000 mg to market a generic equivalent of ...

Metformin, a prescription drug for people with type II diabetes, helps maintain blood glucose levels. Apotex Inc., a Canadian pharmaceutical corporation, is voluntarily recalling some batches of its ...

The polycystic ovary syndrome (PCOS) is defined as the presence of both ovulatory dysfunction and hyperandrogenism. In women with PCOS, oligo- or anovulation manifests itself as irregular cycles with ...

Two pharmaceutical companies recently issued voluntary recalls for extended-release versions of the diabetes drug metformin, because it may contain high levels of a cancer-causing chemical, according ...